605 Page 1 of 2 15 July 2001 Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company Name/Scheme PYC Therapeutics Ltd ACN/ARSN 098 391 961 1. Details of substantial holder (1) Name Retail Employees...
Ceasing to be a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
In the deck
Earlier from PYC Therapeutics
- PKD - Presentation of Clinical Safety Data
- 2026 Corporate Governance Statement
- Appendix 4G
- 2026 Annual Report to Shareholders
- Appendix 4E
Later from PYC Therapeutics
- ADOA Program - Data Presentation
- Investor Webinar Presentation Q3 2026
- S&P DJI Announces September 2026 Quarterly Rebalance
- PKD - First Patient Dosed in OLE Study
- RP11 program - presentation at Euretina 2026
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics